Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Barinthus Biotherapeutics plc - American Depositary Shares
(NQ:
BRNS
)
0.6801
UNCHANGED
Streaming Delayed Price
Updated: 3:35 PM EDT, May 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Barinthus Biotherapeutics plc - American Depositary Shares
< Previous
1
2
Next >
Barinthus Biotherapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS
May 11, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Halper Sadeh LLC is Investigating Whether TBRG, SILA, BRNS are Obtaining Fair Deals for their Shareholders
April 30, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments
April 30, 2026
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments
March 13, 2026
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
December 10, 2025
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Halper Sadeh LLC Encourages HFWA, BRNS, FITB Shareholders to Contact the Firm to Discuss Their Rights
November 20, 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
From
Halper Sadeh LLC
Via
GlobeNewswire
Halper Sadeh LLC Encourages HFWA, FITB, AVDL, BRNS Shareholders to Contact the Firm to Discuss Their Rights
November 18, 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights
From
Halper Sadeh LLC
Via
GlobeNewswire
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
November 07, 2025
From
Barinthus Biotherapeutics
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
October 16, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates DAY, BRNS, ETNB, VRNT on Behalf of Shareholders
October 08, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
October 08, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECO, BRNS, VRNT on Behalf of Shareholders
October 04, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS
October 03, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics plc Is Fair to Shareholders
September 30, 2025
From
Halper Sadeh LLC
Via
Business Wire
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
September 30, 2025
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
August 07, 2025
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Q2 Virtual Investor Summit: Presentations Available Now
June 25, 2025
Via
ACCESS Newswire
Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025
June 09, 2025
Via
ACCESS Newswire
Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
May 07, 2025
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
March 20, 2025
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
March 18, 2025
Via
ACCESS Newswire
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
March 06, 2025
Via
ACCESS Newswire
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
January 10, 2025
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
November 25, 2024
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
November 15, 2024
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
November 15, 2024
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results
November 06, 2024
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences
October 31, 2024
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer
October 01, 2024
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
September 24, 2024
From
Barinthus Biotherapeutics
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
